Gastrointesttinal Tract

77. Kudoh, K., Shimizu, J., Ishiyama, A., Wada, M., Takita, T., Kanke Y., Innami, S., Secretion and excretion of immunoglobulin A to cecum and feces differ with type of indigestible saccharides, J. Nutr. Sci. Vitaminol., 45, 173-181, 1999.

78. Kudoh, K., Shimizu, J., Ishiyama, A., Wada, M., Takita, T., Kanke Y., Innami, S., Effect of indigestible saccharides on B lymphocyte response of intestinal mucosa and cecal fermentation in rats, J. Nutr. Sci. Vitaminol., 44, 103-112, 1998.

79. Pratt, V. C., Tappenden, K. A., McBurney, M. I., Field, C. J., Short-chain fatty acid-supplemented total parenteral nutrition improves nonspecific immunity after intestinal resection in rats, J. Parenter. Enter. Nutr., 20, 264-271, 1996.

80. Bohmig, G. A., Krieger, P-M., Saemann, M. D., Wenhardt, C., Pohanka, E., Zlabinger, G. J., N-Butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids, Immunology, 92, 234-243, 1997.

81. Inan, M. S., Rasoulpour, R. J., Yin, L., Hubbard, A. K., Rosenberg, D. W., Giardina,

C., The luminal short-chain fatty acid butyrate modulates NF-CB activity in a human colonic epithelial cell line, Gastroenterology, 118, 724-734, 2000.

82. Jenkins, D. J. A., Kendall, C. W. C., Vuksan V., Inulin, oligofructose, and intestinal function, J. Nutr., 129, 1431S-1433S, 1999.

83. Wu, G., Field, C. J., Marliss, E. B., Glutamine and glucose metabolism in rat sple-nocytes and mesenteric lymph node lymphocytes, Am. J.Physiol., 260, E141-E147, 1991.

84. Xu, D., Lu, Q., Deitch, E. A., Elemental diet-induced bacterial translocation associated with systemic and intestinal immune suppression, J. Parenter. Enter. Nutr., 22, 37-41, 1998.

85. Spaeth, G., Gottwald, T., Specian, R. D., Mainous, M. R., Berg, R. D., Deitch, E. A., Secretory immunoglobulin A, intestinal mucin, and mucosal permeability in nutritionally induced bacterial translocation in rats, Ann. Surg., 220, 798-808, 1994.

86. Satchithanandam, S., Vargofcak-Apker, M., Calvert, R. J., Leeds, A. R., Cassidy, M. M., Alteration of gastrointestinal mucin by fiber feeding in rats, J. Nutr., 120, 1179-1184, 1990.

87. Frankel, W., Zhang, W., Singh, A., Bain, A., Satchithanandam, S., Klurfeld, D. Rombeau, J., Fiber: effect on bacterial translocation and intestinal mucin content, World J. Surg., 19, 144-149, 1994.

88. Deitch, E. A., Xu, D., Lu, Q., Berg, R., Elemental diet-induced immune suppression is caused by both bacterial and dietary factors, J. Parenter. Enter. Nutr., 17, 332-336, 1993.

89. Bustos-Fernandez, L., Ledesma de Paolo, I., Hamamura, S., Gonzalez, E., Celener, D., Caldarini, M. I., Tiscornia, O. M., Does secretin influence rat colonic absorption and secretion? Am. J. Gastroenterol., 70, 265-269, 1978.

90. Barcelo, A., Claustre, J., Moro, F., Chayvialle, J-A., Cuber, J-C., Plaisancie, P., Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon, Gut, 46, 218-224, 2000.

91. Meydani, S. N., Ha, W-K., Immunologic effects of yogurt, Am. J. Clin. Nutr., 71, 861-872, 2000.

92. Robins-Browne, R. M., Path, F. F., Levine, M. M., The fate of ingested lactobacilli in the proximal small intestine, Am. J. Clin. Nutr., 34, 514-519, 1981.

93. Saxelin, M., Colonization of the human gastrointestinal tract by probiotic bacteria, Nutr. Today, 31 (suppl.), 5S, 1996.

94. Chiang, B. L., Sheih, Y. H., Wang, L. H., Liao, C. K. Gill, H. S., Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses, Eur. J. Clin. Nutr., 54, 849-855, 2000.

95. De Simone, C., Ciardi, A., Grassi, A., Lambert-Gardini, S., Tzantzoglou, S., Trinch-ieri, V., Moretti, S., Jirillo, E., Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes, Immunopharmacol. Immunotoxicol., 14, 331-340, 1992.

96. De Simone, C., Tzantzoglou, S., Baldinelli, L., Di Fabio, S., Bianchi Salvadori, B., Jirillo, E., Vesely, R., Enhancement of host resistance against Salmonella typhimurium infection by a diet supplemented with yogurt, Immunopharmacol. Immunotoxicol., 10, 399-415, 1988.

97. De Simone, C., Vesely, R., Negri, R., Bianchi Salvadori, B., Zanzoglu, S., Cilli, A. Lucci, L., Enhancement of immune response of murine Peyer's patches by a diet supplemented with yogurt, Immunopharmacol. Immunotoxicol., 9, 87-100, 1987.

98. Link-Amster, H., Rochat, F., Saudan, K. Y., Mignot, O., Aeschlimann, J. M., Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake, FEMS Immunol. Med. Microbiol., 10, 55-64, 1994.

99. Malin, M., Suomalainen, H., Saxelin, M., Isolauri, E., Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG, Ann. Nutr. Metabol., 40, 137-145, 1996.

100. Matsuzaki, T., Yamazaki, R., Hashimoto, Y., Yokokura, T., The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice, J. Dairy Sci., 81, 48-53, 1998.

101. Moineau, S., Goulet, J., (1991) Effect of feeding fermented milks on the pulmonary macrophage activity in mice, Milchwissenschaft, 46, 551-554, 1991.

102. Perdigon, G., Alvarez, S., Nader de Macias, M. E., Margni, R. A., Oliver, G., Pesce de Ruiz Holgado, A. A., Lactobacilli administered orally induce release of enzymes from peritoneal macrophages in mice, Milchwissenschaft, 41, 344-348, 1986.

103. Perdigon, G., Alvarez, S., Nader de Macias, M. E., Roux, M. E., Pesce de Ruiz Holgado, A., The oral administration of lactic acid bacteria increase the mucosal intestinal immunity in response to enteropathogens, J. Food Protect., 53, 404-410, 1990.

104. Perdigon, G., Alvarez, S., Nader de Macias, M. E., Savoy de Giori, G., Medici, M., Nunez de Kairuz, M., Behaviour of natural and heated yogurt in the immune system and preventive capacity on enteric infections, Milchwissenschaft, 46, 411-416, 1991.

Perdigon, G., Nader de Macias, M. E., Alvarez, S., Medici, M., Oliver, G., Pesce de Ruiz Holgado, A., Effect of a mixture of Lactobacillus casei and Lactobacillus acidophilus administered orally on the immune system in mice, J. Food Protect., 49, 986-989, 1986.

Perdigon, G., Nader de Macias, M. E., Alvarez, S., Medici, M., Oliver, G., Pesce de Ruiz Holgado, A., Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus, Immunology, 63, 17-23, 1988.

Perdigon, G., Nader de Macias, M. E., Alvarez, S., Oliver, G., Pesce de Ruiz Holgado, A., Effect of perorally administered lactobacilli on macrophage activation in mice, Infect. Immun., 53, 404-410, 1986.

Perdigon, G., Nader de Macias, M. E., Alvarez, S., Oliver, G., Pesce de Ruiz Holgado, A., Enhancement of immune response in mice fed with Streptococcus thermophilus and Lactobacillus acidophilus, J. Dairy Sci., 70, 919-926, 1987. Schiffrin, E. J., Rochat, F., Link-Amster, H., Aeschlimann, J. M., Donnet-Hughes, A., Immunomodulation of human blood cells following the ingestion of lactic acid bacteria, J. Dairy Sci., 78, 491-497, 1995.

Shu, Q., Lin, H., Rutherford, K. J., Fenwick, S. G., Prasad, J., Gopal, P. K., Gill, H. S., Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice, Microbiol. Immunol., 44, 213-222, 2000. Takahashi, T., Nakagawa, E., Nara, T., Yajima, T., Kuwata, T., Effects of orally ingested Bifidobacterium longum on the mucosal IgA response of mice to dietary antigens, Biosci. Biotechnol. Biochem., 62, 10-15, 1998.

Takahashi, T., Oka, T., Iwana, H., Kuwata, T., Yamamoto, Y., Immune response of mice to orally administered lactic acid bacteria, Biosci. Biotechnol. Biochem., 57, 1557-1560, 1993.

Tejada-Simon, M. V., Lee, J. H., Ustunol, Z., Pestka, J. J., Ingestion of yogurt containing Lactobacillus acidophilus and bifidobacterium to potentiate immunoglobulin A responses to cholera toxin in mice, J. Dairy Sci., 82, 649-660, 1999. Yasui, H., Mike, A., Ohwaki, M., Immunogenicity of Bifidobacterium breve and change in antibody production in Peyer's patches after oral administration, J. Dairy Sci., 72, 30-35, 1989.

Berg, R. D., Indigenous intestinal microflora and the host immune response, EOS J. Immunol. Immunopharmacol., 4, 161-168, 1985.

Marin, M. L., Lee, J. H., Murtha, J., Ustunol, Z., Pestka J. J., Differential cytokine production in clonal macrophage and T-cell lines cultured with bifidobacteria, J. Dairy Sci., 80, 2713-2720, 1997.

Park, S. Y., Ji, G. E., Ko, Y. T., Jung, H. K., Ustunol, Z., Pestka, J. J., Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of bifidobacterium, Int. J. Food Microbiol., 46, 231-241, 1999.

Yasui, H., Ohwaki, M., Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve, J. Dairy Sci., 74, 1187-1195, 1991. Solis Pereyra, B., Lemonnier, D., Induction of human cytokines by bacteria used in dairy foods, Nutr. Res., 13, 1127-1140, 1993.

Tejada-Simon, M. V., Ustunol, Z., Pestka, J. J., Ex vivo effects of lactobacilli, streptococci, and bifidobacteria ingestion on cytokine and nitric oxide production in a murine model, J. Food Protect., 62, 162-169, 1999.

Hatcher, G. E., Lambrecht, R. S., (1993) Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria, J. Dairy Sci., 76, 2485-2492, 1993.

De Simone, C., Grassi, P. P., Bianchi Salvadori, B., Miragliotta, G., Vesely, R., Jirillo, E., Adherence of specific yogurt microorganisms to human peripheral blood lymphocytes, Microbios, 55, 49-57, 1988.

Marteau, P., Boutron-Ruault, M. C., Nutritional advantages of probiotics and prebi-otics, Br. J. Nutr, 87 (suppl.), S153-S157, 2002.

Kleessen, B., Hartmann, L., Blaut, M., Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins, and mucosa-associated bifidobacte-ria in gnotobiotic animals, Br. J. Nutr., 89, 597-606, 2003.

Fontaine, N., Meslin, J. C., Lory, S., Andrieux, C., Intestinal mucin distribution in the germ-free rat and in the heteroxenic rat harbouring a human bacterial flora: effects of inulin in the diet, Br. J. Nutr., 75, 881-892, 1996.

Cassidy, M. M., Satchitanandam, S., Calvert, R. J., Vahouny, G. V., Leeds, A. R., Quantitative and qualitative adaptations in gastrointestinal mucin with dietary fiber feeding, in Dietary Fiber Chemistry, Physiology, and Health Effects, Kritchevsky, D., Bonfield, C., Anderson, W., Eds., Plenum Press, New York and London, pp. 67-88, 1990.

Rhodes, J. M., Colonic mucus and mucosal glycoproteins: the key to colitis and cancer? Gut, 30, 1660-1666, 1989.

Satchithanandam, S., Vargofcak-Apker, M., Calvert, R. J., Leeds, A. R., Cassidy, M. M., Alteration of gastrointesttinal mucin by dietary fiber feeding in rats, J. Nutr., 120, 1179-1184, 1990.

Berg, R. D., Garlington, A. W., Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model, Infect. Immun., 23, 403-411, 1979.

Deitch, E. A., Maejima, K., Berg, R. D., Effect of oral antibiotics and bacterial overgrowth on the translocation of the GI tract microflora in burned rats, J. Trauma, 25, 385-392, 1985.

Spaeth, G., Berg, R. D., Specian, R. D., Deitch, E. A., Food without fibre promotes bacterial translocation from the gut, Surgery, 108, 240-247, 1990.

May, T., Mackie, R. I., Fahey, G. C., Cremin, J. C., Garleb, K. A., Effect of fiber source on short-chain fatty acid production on the growth and toxin production by

Clostridium difficile, Scand. J. Gastroenterol., 19, 916-922, 1994.

May, T., Mackie, R. I., Garleb, K. A., Effect of dietary oligosaccharides on intestinal growth of and tissue damage by Clostridium difficile, Microecol. Therapy, 23,

158-170, 1995.

Oike, H., Matsuoka, R., Tashiro, Y., Hirayama, M., Tamura, Z., Yamazaki, S., Effect of Bifidobacterium-monoassociation and feeding of fructooligosaccharides on lethal activity of enterohemorrhagic Escherichia coli O157 in germ-free mice, Biosci. Microflora, 18, 101-107, 1999.

Karmali, M. A., Petric, M., Lim, C., Freming, P. C., Arbus, G. S., Lior, H., The association between idiopathic haemolytic uremic syndrome and infection by vero-toxin-producing Escherichia coli, J. Infect. Dis., 151, 775-782, 1985. Riley, L. W., Remis, R. S., Helegerson, S. D., McGee, H. B., Wells, J. G., Davis, B. R., Herbert, R. J., Olcott, E. S., Johnson, L. M., Hargrett, N. T., Blake, P. A., Cohen, M. L., Hemorrhagic colitis associated with a rare Escherichia coli serotype, N. Engl. J. Med., 308, 681-685, 1983.

Buddington, K. K., Donahoo, J. B., Buddington, R. K., Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumor inducers, J. Nutr., 132, 472-477, 2002.

Oli, M. W., Petschow, B. W., Buddington, R. K., Evaluation of fructooligosaccharide supplementation of oral electrolyte solutions for treatment of diarrhoea, Dig. Dis. Sci, 43, 138-147, 1998.

ten Bruggencate S. J. M., Bovee-Oudenhoven, I. M. J., Lettink-Wissink, M. L. G., Van der Meer, R., Dietary fructo-oligosaccharides dose-dependently increase translocation of salmonella in rats, J. Nutr., 133, 2313-2318, 2003. Bovee-Oudenhoven, I. M. J., ten Bruggencate S. J. M., Lettink-Wissink, M. L. G., van der Meer, R., Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of salmonella in rats, Gut, 52, 1572-1578, 2003.

Bovee-Oudenhoven, I. M. J., Klaasen, H. L. B. M., Lapre, J. A., Weerkamp, A. H., van der Meer, R., Nitric oxide-derived urinary nitrate as a marker of intestinal bacterial translocation in rats, Gastroenterology, 107, 47-53, 1994.

Bovee-Oudenhoven, I. M. J., Termont, D. S. M. L., Heidt, P. J., van der Meer, R., Increasing the intestinal resistance of rats to the invasive pathogen Salmonella enter-itidis: additive effects of lactulose and calcium, Gut, 40, 497-504, 1997. Argenzio, R. A., Meuten, D. J., Short-chain fatty acids induce reversible injury of porcine colon, Dig. Dis. Sci., 36, 1459-1468, 1991.

Koster-Kamphuis, L., van Straaten, E. A., Kors, W. A., De Schrijver, J. E. A. R., Bovee-Oudenhoven, I. M. Y., van der Meer, R., Forget, P. Ph., Urinary NOx:creatinine ratios during gluten challenge in children with celiac disease, J. Pediatr. Gastroenterol. Nutr., 36, 372-375, 2003.

Koo, H-N., Hong, S-H., Seo, H-G., Yoo, T-S., Lee, K-N., Kim, N-S., Kim, C-H., Kim, H-M., Inulin stimulates NO synthesis via activation of PKC-D and protein tyrosine kinase, resulting in activation of NF-DB by IFN-Qprimed RAW 264.7 cells, J. Nutr. Biochem., 14, 598-605, 2003.

Bovee-Oudenhoven, I. M. J., Dietary modulation of the resistance to intestinal infections, Ph. D. Thesis, Landbouwuniversiteit, Wageningen, The Netherlands, pp. 14-15, 1998.

Bovee-Oudenhoven, I. M. J., Termont, D. S. M. L., Weerkamp, A. H., Faassen-Peters, M. A. W., van der Meer, R., Dietary calcium inhibits the intestinal colonization and translocation of Salmonella in rats, Gastroenterology, 113, 550-557, 1997. Govers, M. J. A. P., van der Meer, R., Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids, Gut, 34, 365-370, 1993.

Newmark, H. L., Wargovich, M. J., Bruce, W. R., Colon cancer and dietary fat, phosphate and calcium: a hypothesis, J. Natl. Cancer Inst., 72, 1323-1325, 1984. Wargovich, M. J., Eng, V. W., Newmark, H. T., Bruce, W. R., Calcium ameliorates the toxic effect of deoxycholate on colonic epithelium, Carcinogenesis, 4, 1205-1207, 1983.

Wargovich, M. J., Eng, V. W., Newmark, H. T., Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium, Cancer Lett., 23, 253-258, 1984.

Appleton, G. V. N., Owen, R. W., Wheeler, E. E., Challacombe, D. N., Williamson, R. C. N., Effect of dietary calcium on the colonic luminal environment, Gut, 32, 1374-1377, 1991.

153. Govers, M. J. A. P., Termont, D. S. M. L., van der Meer, R., Mechanism of the antiproliferative effect of milk mineral and other calcium supplements on colonic epithelium, Cancer Res, 54, 95-100, 1994.

154. Lipkin, M., Newmark, H., Calcium and the prevention of colon cancer, J. Cellul. Biochem., 22 (suppl.), 65-73, 1995.

155. Scalmati, A., Lipkin, M., Newmark, H., Calcium, vitamin D, and colon cancer, Clin. Appl. Nutr., 2, 67-74, 1992.

156. Kleeman, E. G., Klaenhammer, T. R., Adherence of Lactobacillus species to human fetal intestinal cells, J. Dairy Sci., 65, 2063-2069, 1982.

157. Remesy, C., Levrat, M. A., Gamet, L., Demigne, C., Cecal fermentations in rats fed oligosaccharides (inulin) are modulated by dietary calcium level, Am. J. Physiol., 264, G855-G862, 1993.

158. Newmark, H. L., Nutrient density: an important and useful tool for laboratory animal studies, Carcinogensis, 8, 871-873, 1987.

159. Delzenne, N., Aertssens, J., Verplaetse, H., Roccaro, M., Roberfroid, M., Effect of fermentable fructo-oligosaccharides on mineral, nitrogen and energy digestive balance in the rat, Life Sci., 17, 1579-1587, 1995.

160. Cummings, J. H., Southgate, D. A. T., Branch, W. J., Wiggins, H. S., Houston, H., Jenkins, D. J. A., Jivray, T., Hill, M., The digestion of pectin in the human gut and its effect on calcium absorption and large bowel function, Br J. Nutr., 41, 477-485, 1979.

161. Pierre, F., Perrin, P., Champ, M., Bornet, F., Meflah, K., Menanteau, J., Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice, Cancer Res., 57, 225-228, 1997.

162. Cummings, J. H., Pommare, E. W., Branch, W. J., Naylor, C. P. E., Macfarlane, G. T., Short chain fatty acids in human large intestine, portal, hepatic, and venous blood, Gut, 28, 1221-1227, 1987.

163. Pool-Zobel, B., Van Loo, J., Rowland, I., Roberfroid, M. B., Experimental evidences on the potential of prebiotic fructans to reduce the risk of cancer, Br J. Nutr., 87 (suppl. 2), S273-S281, 2002.

164. Hughes, R., Rowland, I. R., Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon, Carcinogenesis, 22, 43-47, 2001

165. Wang, X., Gibson, G. R., Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine, J. Appl. Microbiol., 75, 373-380, 1993.

166. Gibson, G. R., Wang, W., Regulatory effects of bifidobacteria on the growth of other colonic bacteria, J. Appl. Microbiol., 77, 412-420, 1994.

167. Fooks, L. J., Gibson, G. R., In vitro investigations of the effect of probiotics and prebiotics on selected human intestinal pathogens, FEMS Microb. Ecol., 39, 67-75, 2002.

168. Rao, C. V., Chou, D., Simi, B., Ku, H., Reddy, B. S., Prevention of colonic aberrant crypt foci and modulation of large bowel microbial activity by dietary coffee fiber, inulin, and pectin, Carcinogenesis, 20, 1815-1819, 1999.

169. Rowland, I. R., Rumney, C. J., Coutts, J. T., Lievense, L. C., Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats, Carcinogenesis, 19, 281-285, 1998.

170. Buddington, R. K., Williams, C. H., Chen, S-C., Witherly, S. A., Dietary supplement of Neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects, Am. J. Clin. Nutr., 63, 709-716, 1996.

Bouhnik, Y., Flourie, B., Andrieux, C., Bisetti, N., Briet, F., Rambaud, J-C., Effects of Bifidobacterium sp fermented milk ingested with or without inulin on colonic bifidobacteria and enzymatic activities in healthy humans, Eur. J. Clin. Nutr., 50, 269-273, 1996.

Bouhnik, Y., Flourie, B., Riottot, M., Bisetti, N., Gailing, M-F., Guibert, A., Bornet, F., Rambaud, J-C., Effect of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans, Nutr. Cancer, 26, 21-29, 1996.

Kleessen, B., Sykura, B., Zunft, H-J., Blaut, M., Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons, Am. J. Clin. Nutr., 65, 1397-1402, 1997.

McBain, A. J., Macfarlane, G. T., Modulation of genotoxic enzyme activities by non-digestible oligosaccharide metabolism in in vitro human gut bacterial ecosystems, J. Med. Microbiol., 50, 833-842, 2001.

Roland, N., Interactions des fibers alimentaires avec les enzymes du métabolisme des xénobiotiques chez le rat hétéroxénisé avec une flore humaine, Thèse de Doctorat d'Université, Université de Paris-Sud, Paris, 1994.

Kelly-Quagliana, K. A., Nelson, P. D., Buddington, R. K., Dietary oligofructose and inulin modulate immune functions in mice, Nutr. Res., 23, 257-267, 2003. Hosono, A., Ozawa, A., Kato, R., Ohnishi, Y., Nakanishi, Y., Kimura, T., Nakamura, R., Dietary fructooligosaccharides induce immunoregulation of intestinal IgA secretion by murine Peyer's patch cells, Biosci. Biotechnol. Biochem., 67, 758-764, 2003. Roller, M., Rechkemmer, G., Watzl, B., Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immnune functions in rats, J. Nutr., 134, 153-156, 2004. Roller, M., Fermia, A. P., Caderni, G., Rechkemmer, G., Watzl, B., Intestinal immunity of rats with azoxymethane-induced colon cancer is modulated by inulin enriched with oligofructose combined with Lactobacillus rhamnosus and Bifidobacterium lactis, Carcinogenesis, in press, 2004.

Field, C. J., McBurney, M. I., Massimino, S., Heyek, M. G., Sunvold, G. D., The fermentable fiber content of the diet alters the function and composition of canine gut associated lymphoid tissue, Veter. Immunol. Immunopathol., 72, 325-341, 1999. Schley, P. D., Field, C. J., The immune-enhancing effects of dietary fibers and prebiotics, Br. J. Nutr., 87 (suppl. 2), S221-S230, 2002.

Swanson, K. S., Grieshop, C. M., Flickinger, E. A., Bauer, L. L., Healy, H-P., Dawson, K. A., Merchen, N. R., Fahey, G. C., Supplemental fructooligosaccharides and man-nooligosaccharides influence immune function, ileal and total tract nutrient digestibilities, microbial populations and concentrations of protein catabolites in the large bowel of dogs, J. Nutr., 132, 980-989, 2002.

Buddington, K. K., Donahoo, J. B., Buddington, R. K., Dietary oligofructose and inulin provide protection against some enteric and systemic pathogens and cancer challenges, J. Nutr., 132, 472-477, 2002.

Maassen, C. B. M., Laman, J. D., Boersma, W. J. A., Claassen, E., Modulation of cytokine expression by lactobacilli and its possible therapeutic use, in Probiotics 3 — Immunomodulation by the Gut Microflora and Probiotics, Fuller, R., Perdigon, G. Eds., Kluwer Academic, Dordrecht, The Netherlands, pp. 176-192, 2000. Yasui, H., Shida, K., Matsuzaki, T., Yokukara, T., Immunomodulatory function of lactic acid bacteria, Anton. Van Leeuwenhoek, 76, 383-389, 1999. Majarmsa, H., Isolauri, E., Probiotics: a novel approach in the management of food allergy, J. Allergy Clin. Immunol., 99, 179-186, 1997.

Guigoz, Y., Rochat, F., Perruisseau-Carrier, G., Rochat, I., Schiffrin, E. J., Effects of oligosaccharide on the faecal flora and non-specific immune system in elderly people, Nutr. Res., 22, 13-25, 2002.

Chak, A., Banwell, J. G., Traveller's diarrhoea, Acute Infect. Diarr., 22, 549-561, 1993.

Cartwright, R. T., Traveller's diarrhoea, Br. Med. Bull., 49, 348-362, 1993. Farthing, M. J. G., Traveller's diarrhoea, Gut, 35, 1-4, 1994.

Castelli, F., Carosi, G., Epidemiology of Traveller's diarrhoea, Chemotherapy, 41, 20-32, 1995.

Black, R. E., Epidemiology of traveller's diarrhoea and relative importance of various pathogens, Rev. Infect. Dis., 12, 873-879, 1990.

DuPont, H. L., Khan, F. M., Traveller's diarrhoea: epidemiology, microbiology, prevention, and therapy, J. Travel Med., 1, 84-93, 1994.

Lewis, S. J., Freedman, A. R., Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease, Aliment. Pharmacol. Ther., 12, 807-822, 1998.

Oksanen, P. K., Salminen, S., Saxelin, M., Hamalainen, P., Ihantola-Vormisto, A., Muurasniemi-Isoviita, L., Nikkari, S., Oksanen, T., Porsti, I., Salminen, E., Siitoneen, S., Stuckey, H., Toppila, A., Vapaatalo, H., Prevention of travellers' diarrhoea by Lactobacillus GG, Ann. Med., 22, 53-56, 1990.

Cummings, J. H., Christie, S., Cole, T. J., A study of fructo-oligosaccharides in prevention of travellers' diarrhoea, Aliment. Pharmacol. Ther., 15, 1139-1145, 2001. Garcia-Fuente, A., Antolin, M., Guarner, F., Crespo, E., Salass, A., Forcada, P., Laguarda, M., Gavalda, J., Baena, J. A., Vilaseca, J., Malagelada, J. R., Incrimination of anaerobic bacteria in the induction of experimental colitis, Am. J. Physiol., 272, G10-G15, 1997.

Harper, P. H., Lee, E. C. G., Kettlewell, M. G. W., Bennett, M. K., Jewel, D. P., Role of fecal stream in the maintenance of Crohn's colitis, Gut, 26, 279-284, 1985. Macpherson, A., Khoo, U. Y., Philpott-Howard, J., Bjarnason, I., Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria, Gut, 38, 36375, 1996.

Rutgeers, P., Hiele, M., Geboes, K., Peeters, M., Pennincks, F., Aerts, R., Kerremans, R., Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection, Gastroenterology, 114, 262-267, 1998. Rutgeers, P., Geboes, K., Peeters, M., Hiele, M., Pennincks, F., Aerts, R., Kerremans, R., Vantrappen, G., Effect of fecal stream diversion on recurrence of Crohn's disease in neoterminal ileum, Lancet, 338, 771-774, 1991.

Taurog, J. D., Richardson, J. A., Croft, J. T., Simmons, W. A., Zhou, M., Fernandez-Sueiro, J. L., Balish, E., Hammer, R. E., The germ-free state prevents deveopment of gut and joint inflammatory disease in HLA-B27 transgenic rats, J. Exp. Med., 180, 2359-2364, 1994.

Sellon, R. K., Tonkonogy, S., Schultz, M., Dielman, L. A., Grenther, W., Balish, E., Renninck, D. M., Santor, R. B., Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10 deficient mice, Infect. Immun., 66, 5224-5231, 1998.

Schultz, Tonkonogy, S., M., Sellon, R. K., Veltkamp, G., Godfrey, V. L., Kwon, J., Grenther, W., Balish, E., Horak, I., Santor, R. B., IL-2 deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation, Am. J. Phys-iol., 276, G1461-G1472, 1999.

Wolf, B. W., Meulbroek, J. A., Jarvis, K. P., Wheeler, K. B., Garleb, K. A., Dietary supplementation with fructooligosaccharides increases survival time in a hamster model of Clostridium difficile colitis, Biosci. Microflora, 16, 59-64, 1997. Videla, S., Vilaseca, J., Antolin, M., Garcia-Lafuente, A., Guarner, F., Crespo, E., Casalots, J., Salas, A., Malagelada, J. R., Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat, Am. J. Gastroenterol., 96, 1486-1493, 2001. Cherbut, C., Michel, C., Lecannu, G., The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats, J. Nutr., 133, 21-27, 2003.

Welters, C. F. M., Heineman, E., Thunissen, F. B. J. M., van den Bogaard, A. E. J. M., Dipbact, D. T. V. M., Soeters, P. B., Baeten, C. G. M. I., Effects of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouchanal anastomosis, Dis. Colon Rectum, 45, 621-627, 2002.

Hunter, J. O., Tuffnell, Q., Lee, A. J., Controlled trial of oligofructose in the management of irritable bowel syndrome, J. Nutr., 129, 1451S-1453S, 1999. Neu, J., Necrotizing enterocolitis: The search for a unifying pathogenic theory leading to prevention, Pediatr. Clin. North Am., 43, 409-432, 1996.

Claud, E. C., Walker, A., Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis, FASEB J., 15, 1398-1403, 2001. Butel, M. J., Waligora-Dupriet, A. J., Szylit, O., Oligofructose and experimental model of neonatal necrotising enterocolitis, Br. J. Nutr., 87 (suppl. 2), S213-S219, 2002.

Bousseboua, H., Le Coz, Y., Dabard, J., Szylit, O., Raibaud, P., Popoff, M. R., Ravisse, P., Experimental cecitis in gnotobiotic quails monoassociated with Clostridium butyri-cum strains isolated from patients with neonatal necrotizing enterocolitis and from healthy newborns, Infect. Immun., 57, 932-936, 1989.

Butel, M. J., Catala, I., Tessédre, A. C., Bensaada, M., Durao, J., Szylit, O., 1998 Are all bacteria involved in neonatal necrotising enterocolitis responsible for the disease? Proceedings of the 2nd World Congress Anaerobic Bacteria Infections, Nice, France, October 3-6, 1998.

Butel, M. J., Szylit, O., Bifidobacteria in necrotizing enterocolitis. Gastroenterology, 118, 1280-1281, 2000.

Butel, M. J., Roland, N., Hibert, F., Popot, F., Favre, A., Tessedre, A. C., Bensaada, M., Rimbault, A., Szylit, O., Clostridial pathogenicity in experimental necrotizing enterocolitis in gnotobiotic quails and protective role of bifidobacteria, J. Med. Microbiol., 47, 391-399, 1998.

Catala, I., Butel, M. J., Bensaada, M., Popot, F., Tessédre, A. C., Rimbault, A., Szylit, O., Oligofructose contributes to the protective role of bifidobacteria in experimental necrotising enterocolitis in quails. J. Med. Microbiol., 48, 89-94, 1999. Butel, M. J., Catala, I., Waligora-Dupriet, A. J., Taper, H., Tessedre, A. C., Durao, J., Szylit, O., Protective effect of dietary oligofructose against cecitis induced by clostridia in gnotobiotic quails, Microb. Ecol. Health Dis., 13, 166-172, 2001. Doll, R., The lessons of life: Keynote address to the Nutrition and Cancer Conference, Cancer Res., 52 (suppl), 2024s-2029s, 1992.

Doll, R., Nature and nurture: possibilities for cancer control, Carcinogenesis, 17, 177-184, 1996.

Pool-Zobel, B., Van Loo, J.,Rowland, I., Roberfroid, M., Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer, Br. J. Nutr., 87 (suppl. 2), S273-281, 2002.

221. Bird, R. P., Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings, Cancer Lett., 37, 147-151, 1987.

222. Pereira, M. A., Barnes, L. H., Rassman, V. L., Kelloff, G. V., Steele, V. E., Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents, Carcinogenesis, 15, 1049-1054, 1994.

223. Wargovich, M. J., Harris, C., Chen, C. D., Palmer, C., Steele, V. E., Kelloff, G., Growth kinetics and chemoprevention of aberrant crypts in the rat colon, J. Cellul. Biochem., (suppl.) 15G, 51-54, 1992.

224. Pool-Zobel, B. L., Neudecker, C., Domizlaff, I., Ji, S., Schillinger, U., Rumney, C. J., Moretti, M., Villarini, M., Scassellati-Sforzolini, G., Rowland, I. R., Lactobacillus-and Bifidobacterium-mediated antigenotoxicity in colon cells of rats: prevention of carcinogen-induced damage in vivo and elucidation of involved mechanisms, Nutr. Canc., 26, 365-380, 1996.

225. Magnuson, B., Carr, I., Bied, R. P., Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid, Cancer Res., 53, 4499-4504, 1993.

226. Verghese, M., Rao, D. R., Chawan, C. B., Shackelford, L., Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats, J. Nutr., 132, 2804-2808, 2002.

227. Reddy, B. S., Hamid, R., Rao, C. V., Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition, Carcinogenesis, 18, 1371-1374, 1997.

228. Gallaher, D. D., Stallings, W. H., Blessing, L. L., Busta, F. F., Brady, L. J., Probiotics, cecal microflora, and aberrant crypts in the rat colon, J. Nutr., 126, 1362-1371, 1996.

229. Gallaher, D. D., Khil, J., The effect of synbiotics on colon carcinogenesis, J. Nutr., 129, 1483S-1487S, 1999.

230. Reddy, B. S., Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth, J. Nutr., 129 (suppl.), 1478S-1482S, 1999.

231. Koo, M., Rao, V., Long-term effect of Bifdobacteria and Neosugar on precursor lesions of colonic cancer in CF1 mice, Nutr. Cancer, 16, 249-257, 1991.

232. Bolognani, F., Rumney, C. J., Pool-Zobel, B. L., Rowland, I. R., Effect of lactobacilli, bifidobacteria, and inulin on the formation of aberrant crypt foci in rats, Eur. J. Nutr., 40, 293-300, 2001.

233. Verghese, M., Rao, D. R., Chawan, C. B., Williams, L. L., Shackelford, L., Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats, J. Nutr., 132, 2809-2813, 2002.

234. Poulsen, M., Molck, A. M., Jacobsen, B. L., Different effects of short- and long-chained fructans on large intestinal physiology and carcinogen-induced aberrant crypt foci in rats, Nutr. Cancer, 42, 194-205, 2002.

235. Femia, A. P., Luceri, C., Dolara, P., Giannini, A., Biggeri, A., Salvadori, M., Clune, Y., Collins, K. J., Paglierani, M., Caderni, G., Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogen-esis in rats, Carcinogenesis, 23, 1953-1960, 2002.

236. Roberfroid, M. B., Delzenne, N., Preat, V., Modulation of Hepatocarcinogenesis, Annu. Rev. Pharmacol. Toxicol., 31, 163-175, 1991.

237. Miyanishi, K., Takayama, T., Ohi, M., Glutathione S-transferase in normal and cancerous human colon carcinogenesis, Gastroenterology, 121, 865-874, 2001.

Watanabe, K., Kawamori, T., Nakatsugi, S., Wakabayashi, K., COX-2 and iNOS, good targets for chemoprevention of colon cancer, Biofactors, 12, 129-133, 2000. Powell, S. M., Zilz, N., Barclay-Beazer, S., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B., Kinzler, K. W., APC mutations occur early during colorectal tumorigenesis, Nature, 359, 235-237, 1992.

Moser, A. R., Pitot, H. C., Dove, W. F. A., A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse, Science, 247, 322-324, 1990. Mutanen, M., Pjari, A. M., Oikarinen, S. I., Beef induces and rye bran prevents the formation of intestinal polyps in ApcMin mice: relation to b-catenin and PKC isozymes, Carcinogenesis, 21, 1167-1173, 2000.

Pajari, A-M., Rajakangas, J., Paivarinta, E., Kosma, V-M., Rafter, J., Mutanen, M., Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic b-catenin in MIN mice, Int. J. Cancer, 106, 653-660, 2003. Singh, J., Rivernson, A., Tomita, M., Shimamura, S., Ishibashi, N., Reddy, B. S., Bifidobacterium longum, a lactic acid producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis, Carcinogenesis, 18, 833-841, 1997.

Goldin, B. R., Gorbach, S. I., Effect of Lactobacillus acidophilus dietary supplement on 1,2-dimethylhydrazine-dihidrochloride-induced intestinal cancer in rats, J. Natl. Cancer Inst., 64, 263-235, 1980.

Dragsted, L. O., Daneshvar, B., Vogel, U., Autrup, H. N., Wallin, H., Risom, L., Moller, P., Molk, A. M., Hansen, M., Poulsen, H. E., Loft, S., Sucrose-rich diet induces mutations in the rat colon, Cancer Res., 62, 4339-4345, 2002. Kristiansen, E., Meyer, O., Thorup, I., Refined carbohydrate enhancement of aberrant crypt foci (ACF) in rat colon induced by the food-borne carcinogen 2-amino-3-methyl-imidazol(4,5-f)quinoline (IQ), Cancer Lett., 105, 147-151, 1996. Kristiansen, E., Thorup, I., Meyer, O., Influence of different diets on development of DMH-induced aberrant crypt foci and colon tumor incidence in Wistar rats, Nutr. Cancer, 23, 151-159, 1995.

Poulsen, M., Molck, A. M., Thorup, I., Breinholt, V., Meyer, O., The influence of simple sugars and starch given during pre- or post-initiation on aberrant crypt foci in rat colon, Cancer Lett., 167, 135-143, 2001.

Corpet, D. E., Peiffer, G., Tache, S., Glycemic index, nutrient density, and promotion of aberrant crypt foci in rat colon, Nutr. Cancer, 32, 29-36, 1998. Caderni, G., Luceri, C., Lancioni, L., Dolara, P., Dietray sucrose, glucose, fructose, and starches affect colonic functions in rats, Nutr. Cancer, 25, 179-186, 1996. Taper, H. S., Roberfroid, M. B., Influence of inulin and oligofructose on breast cancer and tumor growth, J. Nutr., 129, 1488S-1491S, 1999.

Rockwell, S. C., Kallman, R. F., Fajaro, L. P., Characteristics of a serially transplanted mouse mammary tumor and its tissue culture-adapted derivative, J. Natl. Cancer. Inst., 49, 735-746, 1972.

Taper, H. S., Wooley, G. W., Teller, M. N., Lardis, M. P., A new transplantable mouse liver tumor of spontaneous origin, Cancer Res., 26, 143-148, 1966. Cappucino, J. G., Brown, G. G., Mountain, S. M., Spencer, S. Tarnowski, G. S., Chemotherapeutic studies on a new transplantable mouse liver tumor (Taper liver tumor), Cancer Res., 26, 689-694, 1966.

Taper, H. S., Delzenne, N. M., Roberfroid, M. B., Growth inhibition of transplantable mouse tumors by non-digestible carbohydrates, Int. J. Cancer, 71, 1109-1112, 1997.

256. Taper, H. S., Lemort, C., Roberfroid, M. B., Inhibition effect of dietary inulin and oligofructose on the growth of transplantable mouse tumor, Anticancer Res., 18, 4123-4126, 1998.

257. Taper, H. S., Roberfroid, M. B., Inhibitory effect of dietary inulin or oligofructose on the development of cancer metastases, Anticancer Res., 20, 4291-4294, 2000.

258. Geran, R. J., Greenberg, N. H., Mac Donald M. M., Schumacher A. M., Abbott B. J., Protocols for screening chemical agents and natural products against animal tumors and other biological systems, Cancer Chemother., Rep 3, 1-103, 1972.

259. Taper, H. S., Roberfroid, M. B., Non-toxic potentiation of cancer radiotherapy by dietary oligofructose and inulin, Anticancer Res., 22, 3319-3324, 2002.

260. Taper H. S., Roberfroid M. B., Inulin/oligofructose, and anticancer therapy. Br. J. Nutr., 87 (suppl. 2), 283-286, 2002.

261. Van Loo, J., Jonkers, N., Evaluation in human volunteers of then potential anticarci-nogenic activities of novel nutritional concepts: prebiotics, probiotics, and synbiotics (the SYNCAN project QLK1-1999-00346), Nutr. Metab. Cardiovasc. Dis., 11 (suppl 4), 87-93, 2001.

262. Saavedra, J. M., Tschernia, A., Moore, N., Abi-Hanna, A., Coletta, F., Emenheiser, C., Gastrointestinal function in infants consuming a weaning food supplemented with oligofructose, J. Paedtr. Gastroenterol. Nutr., 29, A95, 1999.

263. Tschernia, A., Moore, N., Abi-Hanna, A., Yolken, R. H., Coletta, F., Emenheiser, C., Effects of long term consumption of a weaning food supplemented with oligofructose, a prebiotic, J. Paedtr. Gastroenterol. Nutr., 29, A58, 1999.

264. Firmansyah, A., Pramita, G., Carrie Fassler, A., Haschke, F., Link-Amster, H., Improved humoral immune response to measles vaccine in infants receiving infant cereal with fructooligosaccharides, J. Paedtr. Gastroenterol Nutr., 31, A521, 2001.

265. Saavedra, J. M., Tschernia, A., Human studies with probiotics and prebiotics: clinical implications, Br. J. Nutr., 87 (suppl. 2), S241-S246, 2002.

100 Weight Loss Tips

100 Weight Loss Tips

Make a plan If you want to lose weight, you need to make a plan for it. Planning involves setting your goals both short term and long term ones. With proper planning, you would be able to have an effective guide on the steps that you want to take, towards losing pounds of weight. Aside from that, it would also keep you motivated.

Get My Free Ebook


Post a comment